Stockscreener 앱 받기
0.9021
5.97%
-0.0573
시간 외 거래:
.92
0.0179
+1.98%
전일 마감가:
$0.9594
열려 있는:
$0.95
하루 거래량:
245.03K
Relative Volume:
0.25
시가총액:
$11.67M
수익:
-
순이익/손실:
$-9.70M
주가수익비율:
-0.8201
EPS:
-1.1
순현금흐름:
$-8.57M
1주 성능:
-10.68%
1개월 성능:
-5.53%
6개월 성능:
-27.83%
1년 성능:
-74.37%
1일 변동 폭
$0.87
$0.9562
1주일 범위
$0.87
$1.03
52주 변동 폭
$0.8099
$5.95
마커 테라퓨틱스 Stock (MRKR) Company Profile
명칭
Marker Therapeutics Inc
전화
(713) 400-6400
주소
2450 HOLCOMBE BLVD, HOUSTON, TX
MRKR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
0.9021 | 12.41M | 0 | -9.70M | -8.57M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
마커 테라퓨틱스 Stock (MRKR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-05 | 개시 | Canaccord Genuity | Buy |
| 2021-03-25 | 개시 | Piper Sandler | Overweight |
| 2021-03-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-05-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | 개시 | ROTH Capital | Buy |
| 2019-03-01 | 개시 | Janney | Buy |
| 2018-12-03 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
모두보기
마커 테라퓨틱스 주식(MRKR)의 최신 뉴스
What Fibonacci levels say about Marker Therapeutics Inc. reboundWeekly Risk Summary & Weekly Momentum Picks - newser.com
Can volume confirm reversal in Marker Therapeutics Inc.July 2025 Recap & Daily Price Action Insights - newser.com
Visual analytics tools that track Marker Therapeutics Inc. performanceQuarterly Trade Report & Comprehensive Market Scan Insights - newser.com
Is Marker Therapeutics Inc. reversing from oversold territoryJuly 2025 Update & AI Driven Stock Reports - newser.com
Does Marker Therapeutics Inc. show high probability of rebound2025 EndofYear Setup & Fast Momentum Entry Tips - newser.com
Technical signs of recovery in Marker Therapeutics Inc.Dividend Hike & Weekly Breakout Watchlists - newser.com
Reversal indicators forming on Marker Therapeutics Inc. stockCEO Change & Long-Term Capital Growth Strategies - newser.com
Marker Therapeutics (NASDAQ: MRKR) to present MT-601 data at ASH; 66% ORR in NHL no ICANS - Stock Titan
Is Marker Therapeutics Inc. stock a buy on dipsJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
Using Python tools to backtest Marker Therapeutics Inc. strategiesJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
Published on: 2025-11-03 00:22:23 - newser.com
How forex fluctuations impact Marker Therapeutics Inc. (GX1) stockTrend Reversal & Free Safe Capital Growth Stock Tips - newser.com
Tools to assess Marker Therapeutics Inc.’s risk profilePortfolio Return Report & Low Volatility Stock Recommendations - newser.com
What makes Marker Therapeutics Inc. (GX1) stock appealing to growth investorsTreasury Yields & Long-Term Growth Plans - newser.com
Published on: 2025-11-02 15:53:33 - earlytimes.in
Does Marker Therapeutics Inc. fit your quant trading model2025 Top Decliners & Weekly Return Optimization Plans - newser.com
Is Marker Therapeutics Inc. (GX1) stock prepared for digital transitionWeekly Investment Report & Community Verified Swing Trade Signals - newser.com
Published on: 2025-10-29 03:27:17 - newser.com
Why Marker Therapeutics Inc. stock could outperform in 2025Exit Point & Real-Time Stock Movement Alerts - fcp.pa.gov.br
What catalysts could drive Marker Therapeutics Inc. stock higherQuarterly Market Summary & Daily Stock Trend Reports - fcp.pa.gov.br
Why Marker Therapeutics Inc. stock is trending among retail traders2025 Earnings Surprises & Risk Adjusted Swing Trade Ideas - fcp.pa.gov.br
Will Marker Therapeutics Inc. stock see insider buying2025 Bull vs Bear & Free Community Consensus Stock Picks - fcp.pa.gov.br
Is Marker Therapeutics Inc. stock near bottom after declineJuly 2025 Rallies & Low Risk Growth Stock Ideas - fcp.pa.gov.br
마커 테라퓨틱스 (MRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):